Letko, Brosseau & Associates’s Profound Medical PROF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.15M | Sell |
1,204,250
-3,600
| -0.3% | -$21.4K | 0.14% | 65 |
|
|
2025
Q1 | $5.92M | Sell |
1,207,850
-3,300
| -0.3% | -$16.2K | 0.13% | 64 |
|
|
2024
Q4 | $8.69M | Buy |
1,211,150
+12,375
| +1% | +$88.8K | 0.17% | 68 |
|
|
2024
Q3 | $9.55M | Hold |
1,198,775
| – | – | 0.17% | 69 |
|
|
2024
Q2 | $10.1M | Sell |
1,198,775
-32,650
| -3% | -$274K | 0.19% | 72 |
|
|
2024
Q1 | $9.95M | Buy |
1,231,425
+53,575
| +5% | +$433K | 0.17% | 71 |
|
|
2023
Q4 | $9.46M | Buy |
1,177,850
+13,725
| +1% | +$110K | 0.17% | 70 |
|
|
2023
Q3 | $11.4M | Sell |
1,164,125
-4,150
| -0.4% | -$40.5K | 0.22% | 70 |
|
|
2023
Q2 | $15M | Sell |
1,168,275
-3,500
| -0.3% | -$44.9K | 0.28% | 70 |
|
|
2023
Q1 | $10.9M | Sell |
1,171,775
-8,650
| -0.7% | -$80.1K | 0.2% | 72 |
|
|
2022
Q4 | $12.6M | Sell |
1,180,425
-75,250
| -6% | -$805K | 0.23% | 78 |
|
|
2022
Q3 | $5.01M | Buy |
1,255,675
+650
| +0.1% | +$2.59K | 0.1% | 78 |
|
|
2022
Q2 | $8.89M | Sell |
1,255,025
-44,100
| -3% | -$312K | 0.16% | 77 |
|
|
2022
Q1 | $11.7M | Buy |
1,299,125
+476,875
| +58% | +$4.3M | 0.17% | 76 |
|
|
2021
Q4 | $9.28M | Buy |
822,250
+4,275
| +0.5% | +$48.2K | 0.13% | 78 |
|
|
2021
Q3 | $11.9M | Buy |
817,975
+6,900
| +0.9% | +$101K | 0.17% | 77 |
|
|
2021
Q2 | $13.2M | Sell |
811,075
-8,825
| -1% | -$144K | 0.18% | 75 |
|
|
2021
Q1 | $16.4M | Sell |
819,900
-19,800
| -2% | -$397K | 0.22% | 73 |
|
|
2020
Q4 | $17.3M | Buy |
839,700
+793,700
| +1,725% | +$16.3M | 0.24% | 70 |
|
|
2020
Q3 | $811K | Buy |
+46,000
| New | +$811K | 0.01% | 86 |
|